India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

Sudarshan Chemical Industries / Equity Bottom-Up

<ul>
<li>Sudarshan Chemical Industries, a global pigment manufacturer, reported Q4 FY26 consolidated revenue of <strong>INR 2,790 crore</strong>, EBITDA of <strong>INR 247 crore</strong> and reduced net debt to <strong>INR 755 crore</strong>.</li>
<li>The acquired business exceeded EBITDA guidance, inventory reduction improved cash flows, and execution remains on track to achieve <strong>€35 million FY27 EBITDA</strong> and <strong>€90–100 million medium-term target</strong>.</li>
<li>The turnaround is gaining momentum. <strong>Sustained EBITDA growth, synergy realization, working capital optimization</strong>, and <strong>continued deleveraging</strong> are expected to drive earnings growth and support further valuation rerating.</li>
</ul>


Sudarshan Chemical Industries, a global pigment manufacturer, reported Q4 FY26 consolidated revenue of INR 2,790 crore, EBITDA of INR 247 crore and reduced net debt to INR 755 crore.
The acquired business exceeded EBITDA guidance, inventory reduction improved cash flows, and execution remains on track to achieve €35 million FY27 EBITDA and €90–100 million medium-term target.
The turnaround is gaining momentum. Sustained EBITDA growth, synergy realization, working capital optimization, and continued deleveraging are expected to drive earnings growth and support further valuation rerating.


Sudarshan Chemical: Heubach Acquisition Starts Delivering Results

Thematic (Sector/Industry)

<ul>
<li>China’s dye and intermediate industry is facing a structural supply reset as environmental inspections, safety audits and compliance requirements force weaker chemical plants to shut or reduce operations. </li>
<li>The disruption has triggered an unprecedented spike in critical intermediates, with reductant prices rising from approximately RMB 25,000/ton at the end of 2025 to around RMB 120,000/ton by July 2026.</li>
<li>China supplies the majority of global dyes and intermediates. Any reduction in reliable Chinese supply creates an opportunity for Indian manufacturers with integrated operations, export relationships and compliant manufacturing assets.</li>
</ul>


China’s dye and intermediate industry is facing a structural supply reset as environmental inspections, safety audits and compliance requirements force weaker chemical plants to shut or reduce operations. 
The disruption has triggered an unprecedented spike in critical intermediates, with reductant prices rising from approximately RMB 25,000/ton at the end of 2025 to around RMB 120,000/ton by July 2026.
China supplies the majority of global dyes and intermediates. Any reduction in reliable Chinese supply creates an opportunity for Indian manufacturers with integrated operations, export relationships and compliant manufacturing assets.


China’s Dye Supply Shock: Why India Could Emerge As A Structural Winner?

Consumer Analyst / Channel Surveillance Specialist, Trudence Capital Advisors

Pranav Bhavsar

Consumer Analyst / Channel Surveillance Specialist

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

<div>
<h3>In this Insight </h3>
<p>Our chemical industry coverage is primarily focused on understanding and analysing supply chain dynamics for our core consumer coverage. In this insight, we present our takeaways from channel interactions that are focused on the industry and specific companies. </p>
<p><strong>Domestic Chemicals: </strong>We interact with a local channel that is focused on the distribution of chemicals catering to the paint and construction industry. The business is upbeat, tailwinds remain and the business prospects for chemicals look good at least for the next two years. </p>
<p><strong><a href="https://www.smartkarma.com/entities/sudarshan-chemical-inds-ltd" target="_blank" data-smartkarma-citation="entities:12968:1" rel="noopener">Sudarshan Chemical Inds (SCHI IN)</a> :</strong> Highly regarded and respected management along with interesting product line up is poised well for growth. </p>
<p><a href="https://www.smartkarma.com/entities/camlin-fine-sciences-ltd" target="_blank" data-smartkarma-citation="entities:17667:1" rel="noopener"><strong>Camlin Fine Sciences (CFIN IN)</strong></a><strong>:</strong> Historical performance has been good and acquisitions offer good growth potential </p>
<p><strong>Clean Science and Technology Limited (Private):</strong> Clean Science a fine chemical manufacturer and also a competitor to CFIN in some products, has recently filed its <a href="https://www.sebi.gov.in/filings/public-issues/apr-2021/clean-science-and-technology-limited-drhp_49777.html" target="_blank" rel="noopener">DRHP</a>. Our channel interactions indicate a robust growth plan ahead. </p>
<h3>About India Channel Insight</h3>
</div>
<div>
<p>Our objective with India Channel Insight is to share snippets from our channel interactions that are part of our research process. These snippets can potentially be signals for larger themes/ideas emerging out of these interactions. </p>
</div>


In this Insight 
Our chemical industry coverage is primarily focused on understanding and analysing supply chain dynamics for our core consumer coverage. In this insight, we present our takeaways from channel interactions that are focused on the industry and specific companies. 
Domestic Chemicals: We interact with a local channel that is focused on the distribution of chemicals catering to the paint and construction industry. The business is upbeat, tailwinds remain and the business prospects for chemicals look good at least for the next two years. 
Sudarshan Chemical Inds (SCHI IN) : Highly regarded and respected management along with interesting product line up is poised well for growth. 
Camlin Fine Sciences (CFIN IN): Historical performance has been good and acquisitions offer good growth potential 
Clean Science and Technology Limited (Private): Clean Science a fine chemical manufacturer and also a competitor to CFIN in some products, has recently filed its DRHP. Our channel interactions indicate a robust growth plan ahead. 
About India Channel Insight


Our objective with India Channel Insight is to share snippets from our channel interactions that are part of our research process. These snippets can potentially be signals for larger themes/ideas emerging out of these interactions. 


India Channel Insights | Chemicals - Sudarshan, Camlin, Clean Science

APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Dorf-Ketal Chemicals Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dorf-ketal-chemicals-ltd" target="_blank" data-smartkarma-citation="entities:44325:1" rel="noopener">Dorf-Ketal Chemicals Ltd (998552Z IN)</a> (DKCI) is looking to raise about US$579m in its upcoming India IPO.</li>
<li>DKCI is an R&amp;D and innovation-focused global manufacturer and supplier of specialty chemicals, catering to hydrocarbons and industrial supply chains, and customers with diverse applications across various industrial segments.</li>
<li>In this note, we talk about the not-so-positive aspects of the deal.</li>
</ul>



Dorf-Ketal Chemicals Ltd (998552Z IN) (DKCI) is looking to raise about US$579m in its upcoming India IPO.
DKCI is an R&amp;D and innovation-focused global manufacturer and supplier of specialty chemicals, catering to hydrocarbons and industrial supply chains, and customers with diverse applications across various industrial segments.
In this note, we talk about the not-so-positive aspects of the deal.


Dorf-Ketal Chemicals India Pre-IPO - The Negatives - Elevated Borrowings and Tariff Uncertainty

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dorf-ketal-chemicals-ltd" target="_blank" data-smartkarma-citation="entities:44325:1" rel="noopener">Dorf-Ketal Chemicals Ltd (998552Z IN)</a> (DKCI) is looking to raise about US$579m in its upcoming India IPO.</li>
<li>DKCI is an R&amp;D and innovation-focused global manufacturer and supplier of specialty chemicals, catering to hydrocarbons and industrial supply chains, and customers with diverse applications across various industrial segments.</li>
<li>In this note, we talk about the positive aspects of the deal.</li>
</ul>



Dorf-Ketal Chemicals Ltd (998552Z IN) (DKCI) is looking to raise about US$579m in its upcoming India IPO.
DKCI is an R&amp;D and innovation-focused global manufacturer and supplier of specialty chemicals, catering to hydrocarbons and industrial supply chains, and customers with diverse applications across various industrial segments.
In this note, we talk about the positive aspects of the deal.


Dorf-Ketal Chemicals India Pre-IPO -The Positives - Strategic Blend of Organic & Inorganic Expansion

India

Sudarshan Chemical Industries is a global leader in pigment manufacturing, offering a comprehensive portfolio of organic, inorganic, and effect pigments, as well as pigment dispersions. These products serve diverse industrial sectors including coatings, plastics, inks, and cosmetics. The company was founded in 1951 and is headquartered in Pune, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sudarshan Chemical Industries (SCHI IN)

Sudarshan Chemical: Heubach Acquisition Starts Delivering Results

Sudarshan Chemical Industries reports strong Q4 FY26 results, exceeding EBITDA guidance and reducing net debt, with focus on sustained growth,...

Sudarshan Bhandari

China’s Dye Supply Shock: Why India Could Emerge As A Structural Winner?

China’s dye and intermediate industry is facing a structural supply reset as environmental inspections, safety audits. This is creating an...

Sudarshan Bhandari

India Channel Insights | Chemicals - Sudarshan, Camlin, Clean Science

In this insight, we present our takeaways from chemical channel interactions that are focused on the chemical industry and specific companies.

Pranav Bhavsar

Dorf-Ketal Chemicals India Pre-IPO - The Negatives - Elevated Borrowings and Tariff Uncertainty

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of...

Akshat Shah

Dorf-Ketal Chemicals India Pre-IPO -The Positives - Strategic Blend of Organic & Inorganic Expansion

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.

Akshat Shah

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Sudarshan Chemical: Heubach Acquisition Starts Delivering Results

​Sudarshan Chemical Industries reports strong Q4 FY26 results, exceeding EBITDA guidance and reducing net debt, with focus on sustained growth,...

Sudarshan Bhandari

China’s Dye Supply Shock: Why India Could Emerge As A Structural Winner?

China’s dye and intermediate industry is facing a structural supply reset as environmental inspections, safety audits. This is creating an...

Sudarshan Bhandari

India Channel Insights | Chemicals - Sudarshan, Camlin, Clean Science

In this insight, we present our takeaways from chemical channel interactions that are focused on the chemical industry and specific companies.

Pranav Bhavsar

Dorf-Ketal Chemicals India Pre-IPO - The Negatives - Elevated Borrowings and Tariff Uncertainty

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of...

Akshat Shah

Dorf-Ketal Chemicals India Pre-IPO -The Positives - Strategic Blend of Organic & Inorganic Expansion

Dorf-Ketal Chemicals India is looking to raise about US$579m in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.

Akshat Shah

Sudarshan Chemical Industries reports strong Q4 FY26 results, exceeding EBITDA guidance and reducing net debt, with focus on sustained growth,...